Supply chain tip of the day: Understand biosimilar nuances before integrating them into the system
By IHOC
Biosimilars, or highly similar but not exact alternatives to biologic drugs, are creating new cost-saving opportunities for health system pharmacies.
However, before integrating biosimilars into a health system, pharmacy leaders must understand their nuances, explained Kristin Chambers, vice president of strategic development at AmerisourceBergen.
To read the full article, as originally published in Becker's Hospital Review, click here.
